YAE1 Antibody

What is YAE1 and why would researchers develop antibodies against it?

YAE1 is an essential protein involved in iron-sulfur (Fe-S) protein biogenesis, specifically functioning in the Cytosolic Iron-sulfur protein Assembly (CIA) machinery. Unlike other CIA components that are needed for assembling many different Fe-S proteins, YAE1 exhibits remarkable target specificity, functioning primarily in the maturation of Rli1 (ABCE1 in humans), an essential Fe-S protein involved in protein synthesis . Antibodies against YAE1 are valuable tools for studying this specific branch of the CIA pathway, enabling researchers to investigate protein-protein interactions, subcellular localization, and functional dynamics of this highly specialized adapter protein.

What is the functional relationship between YAE1 and Lto1?

YAE1 and Lto1 form a tight functional complex that acts as a dedicated adapter, specifically recruiting the Rli1 client protein to the CIA targeting complex (composed of Cia1-Cia2-Mms19) . Methodologically, when studying YAE1 with antibodies, researchers should consider the following:

• Co-immunoprecipitation experiments reveal that YAE1 and Lto1 interact both with each other and with the CIA targeting complex

• This interaction is strengthened when cytosolic Fe-S protein maturation is impaired

• The YAE1-Lto1 complex binds to the CIA targeting complex via Lto1's C-terminal tryptophan residue

• YAE1 mediates contact with the target protein Rli1

Understanding this relationship is crucial when designing experiments with YAE1 antibodies, as the protein's function is intimately connected to its complex formation with Lto1.

What are the human homologs of YAE1 and how conserved is the protein?

The human homolog of yeast YAE1 is YAE1D1 (YAE1 domain-containing protein 1), while the human homolog of Lto1 is ORAOV1 (oral cancer-overexpressed protein 1) . When developing or selecting antibodies against YAE1:

• Consider the high degree of functional conservation - human YAE1D1 and ORAOV1 can fully substitute for their yeast counterparts when co-expressed

• This functional conservation suggests structural similarities that may affect antibody cross-reactivity

• Species-specific antibodies should target regions with sequence divergence while maintaining functionality

• Antibodies targeting conserved epitopes may be useful for cross-species studies

The high conservation of these proteins from yeast to humans indicates their fundamental importance in cellular iron-sulfur protein biogenesis across eukaryotes .

What are key considerations when using YAE1 antibodies for co-immunoprecipitation experiments?

When designing co-immunoprecipitation (co-IP) experiments with YAE1 antibodies to study protein-protein interactions, researchers should consider:

• Interaction strength modulation: The interaction between YAE1-Lto1 and the CIA targeting complex is significantly enhanced when cytosolic Fe-S protein maturation is impaired, such as in cells depleted of the early-acting CIA factor Nbp35

• Complex stability factors: The deca-GX3 motif in Lto1 is crucial for YAE1-Lto1 complex formation

• Epitope accessibility: Ensure antibody epitopes don't interfere with critical interaction domains

• Experimental conditions: Use of tagged versions (e.g., Myc- and HA-tagged YAE1 and Lto1) has been successfully employed for affinity purifications

• Controls: Include experiments with mutated versions of YAE1 or its partners to validate specificity of interactions

Properly designed co-IP experiments can reveal how YAE1 mediates interactions between the CIA targeting complex and specific client proteins like Rli1 .

How should researchers approach the validation of YAE1 antibodies?

Thorough validation of YAE1 antibodies is essential to ensure experimental reliability:

• Specificity testing:

  • Western blot analysis comparing wild-type and YAE1-depleted cells

  • Testing cross-reactivity with the human homolog YAE1D1

  • Evaluating potential cross-reactivity with Lto1/ORAOV1 due to their functional association

• Application-specific validation:

  • For immunoprecipitation: Verify the ability to pull down known interaction partners (Lto1, CIA targeting complex members)

  • For immunofluorescence: Confirm co-localization with known cytosolic CIA components

  • For ChIP applications: Validate using appropriate controls for non-specific binding

• Epitope mapping:

  • Identify which region of YAE1 the antibody recognizes

  • Determine if the epitope is within functionally critical domains that might affect protein interactions

• Sensitivity assessment:

  • Establish detection limits using recombinant protein standards

  • Determine antibody effectiveness at detecting endogenous versus overexpressed protein levels

What methodological approaches can differentiate between YAE1's role in Fe-S cluster assembly versus cluster stability?

Distinguishing between YAE1's function in Fe-S cluster assembly versus its potential role in cluster stability requires carefully designed experiments:

• Light-inducible degradation system:

  • Research has successfully employed a photosensitive degron (psd) system fused to YAE1's C-terminus, allowing for controlled degradation upon blue light exposure

  • This approach enables temporal analysis of YAE1's function at different stages of Fe-S protein maturation

• 55Fe radiolabeling approach:

  • For assembly studies: Deplete YAE1 before 55Fe labeling to assess impact on de novo assembly

  • For stability studies: Perform 55Fe labeling first, then deplete YAE1 and monitor cluster retention over time

  • Research using this methodology demonstrated that YAE1 deficiency primarily affects Fe-S cluster assembly on Rli1 rather than stability of pre-assembled clusters

• Controls and comparisons:

  • Include other Fe-S proteins like Leu1 that don't depend on YAE1 as controls

  • Compare effects of YAE1 depletion with depletion of established CIA components like Nbp35

This methodological approach demonstrated that YAE1 functions specifically in Fe-S cluster assembly on Rli1 rather than stabilizing already formed clusters .

How can YAE1 antibodies be used to investigate the role of specific protein domains in complex formation?

YAE1 and its partner Lto1 contain critical domains that mediate their interactions with each other and with the CIA targeting complex. Antibodies can be powerful tools for dissecting these interactions:

• Mutation-coupled immunoprecipitation approach:

  • Generate mutations in key regions of Lto1 such as the deca-GX3 motif or the C-terminal tryptophan

  • Use YAE1 antibodies to immunoprecipitate these mutants and analyze effects on complex formation

  • Research using this approach revealed that mutations in the deca-GX3 motif affected both YAE1 binding and CIA targeting complex association, while C-terminal tryptophan mutation specifically disrupted CIA targeting complex binding without affecting YAE1 interaction

• Domain-masked epitope accessibility analysis:

  • Use multiple antibodies targeting different epitopes of YAE1

  • Analyze how complex formation affects epitope accessibility

  • This approach can reveal conformational changes induced by protein-protein interactions

• Truncation analysis with antibody detection:

  • Generate truncated versions of YAE1 and use antibodies to detect interaction with partners

  • This method can map minimal domains required for specific interactions

These approaches can elucidate the molecular mechanisms underlying YAE1's adapter function in the CIA pathway .

What are the experimental challenges in studying YAE1's specific role in Rli1 maturation?

Investigating YAE1's highly specific function in Rli1 maturation presents several experimental challenges that researchers should address:

• Essentiality complications:

  • Both YAE1 and Rli1 are essential proteins, making traditional knockout approaches problematic

  • Solution: Use regulatable systems like GAL promoters or degron-based approaches for controlled depletion

  • The psd (photosensitive degron) system enables precise temporal control of YAE1 depletion

• Specificity verification:

  • Demonstrate that YAE1 depletion specifically affects Rli1 but not other Fe-S proteins

  • Methodological approach: Test multiple Fe-S enzymes (e.g., Leu1, sulfite reductase) and CIA components (Nbp35, Nar1) using enzymatic activity assays and 55Fe radiolabeling

  • Research showed YAE1 depletion specifically impaired Rli1 maturation without affecting other Fe-S proteins

• Temporal separation of assembly vs. stability:

  • Design experiments that distinguish between effects on de novo Fe-S cluster assembly versus stability of existing clusters

  • Approach: Perform 55Fe radiolabeling before or after YAE1 depletion to differentiate these processes

• Technical considerations for 55Fe experiments:

  • Incorporate appropriate controls (Leu1) to confirm specificity

  • Account for natural cluster turnover by comparing normal decay rates to depletion effects

  • Include translation inhibitors like cycloheximide to prevent new protein synthesis during depletion experiments

These methodological approaches can help overcome the challenges in studying the unique adapter function of YAE1 in Fe-S protein biogenesis.

How can researchers design experiments to investigate the evolutionary conservation of YAE1 function?

The functional conservation of YAE1 across species presents opportunities for comparative studies:

• Complementation assays:

  • Express human YAE1D1 (and ORAOV1) in yeast cells depleted of endogenous YAE1 (and Lto1)

  • Assess growth restoration and Rli1 Fe-S cluster assembly using 55Fe radiolabeling

  • Research demonstrated that human YAE1D1 and ORAOV1 could fully complement their yeast counterparts, but only when co-expressed

• Domain swapping experiments:

  • Create chimeric proteins with domains from different species

  • Use antibodies against conserved epitopes to track these chimeric proteins

  • Analyze which domains are critical for cross-species functionality

• Comparative interactome analysis:

  • Use antibodies against YAE1/YAE1D1 to perform immunoprecipitation coupled with mass spectrometry

  • Compare interaction partners across species to identify conserved and divergent aspects of YAE1 function

  • This approach can reveal whether the remarkable specificity for Rli1/ABCE1 is maintained across evolution

• Structure-function conservation analysis:

  • Generate mutations in conserved residues across species

  • Assess effects on complex formation and target protein maturation

  • Correlate functional effects with structural features

These approaches can provide insights into the evolutionary conservation of this specialized adapter function in Fe-S protein biogenesis .

How can researchers design antibody-based assays to monitor YAE1-Lto1 complex formation in different cellular conditions?

Monitoring the dynamics of YAE1-Lto1 complex formation under various cellular conditions requires specialized approaches:

• Proximity-based assays:

  • Develop split reporter systems (luciferase, fluorescent proteins) fused to YAE1 and Lto1

  • Use antibodies to validate expression levels and localization independently

  • These systems can provide real-time monitoring of complex formation in living cells

• FRET/BRET-based approaches:

  • Tag YAE1 and Lto1 with appropriate fluorophores or bioluminescent proteins

  • Validate tagging with antibodies to ensure proper expression and localization

  • Monitor energy transfer as an indicator of complex formation under different conditions

• Co-immunoprecipitation under stress conditions:

  • Research shows that interaction between YAE1-Lto1 and the CIA targeting complex is strengthened when cytosolic Fe-S protein maturation is impaired

  • Systematically test different stress conditions (oxidative stress, iron deprivation, CIA component depletion)

  • Quantify changes in complex formation using antibody-based detection methods

• Competitive binding assays:

  • Design peptides mimicking the interaction interfaces

  • Use antibodies to detect displacement of native interactions

  • This approach can identify critical residues and potential regulatory mechanisms

These methods can help elucidate how cellular conditions affect the function of YAE1 as an adapter protein in the CIA machinery.

What considerations are important when developing antibodies against the deca-GX3 motif in Lto1?

The deca-GX3 motif in Lto1 is a critical domain for YAE1-Lto1 complex formation, presenting specific challenges for antibody development:

• Structural considerations:

  • The deca-GX3 motif consists of 10 repeats of a GlyX3 pattern (where X represents any amino acid) spanning approximately 40 residues

  • This unusual structural motif may adopt specific conformations that affect epitope accessibility

  • Consider developing antibodies against different regions of this motif to ensure coverage

• Functional implications:

  • Mutations in the deca-GX3 motif (particularly G33;G37;G41 and G49;G53) severely impair Lto1's interaction with both YAE1 and the CIA targeting complex

  • Antibodies targeting this region might interfere with complex formation

  • Include functional validation to ensure antibodies don't disrupt native protein interactions

• Specificity challenges:

  • The GX3 pattern may have structural similarities to other proteins

  • Perform extensive cross-reactivity testing against proteins with similar motifs

  • Consider using longer epitopes that include unique flanking sequences

• Mutation-specific antibodies:

  • Develop antibodies that can specifically recognize wild-type versus mutated forms of the deca-GX3 motif

  • These could serve as valuable tools for tracking effects of specific mutations on protein localization and interactions

Antibodies targeting this unique structural motif would be valuable tools for understanding its role in mediating the adapter function of the YAE1-Lto1 complex .

How can researchers apply YAE1 antibodies to investigate its potential roles beyond Fe-S protein biogenesis?

While YAE1 has a well-established role in Fe-S cluster assembly on Rli1/ABCE1, exploring potential additional functions requires specialized approaches:

• Unbiased interactome analysis:

  • Perform immunoprecipitation with YAE1 antibodies coupled with mass spectrometry

  • Compare interactomes under different cellular conditions (normal, stress, different cell cycle stages)

  • Validate novel interactions with reciprocal co-immunoprecipitation and colocalization studies

• Functional screening approaches:

  • Use YAE1 antibodies to monitor changes in localization or expression under various cellular perturbations

  • Correlate these changes with phenotypic outcomes

  • This may reveal condition-specific functions not directly related to Fe-S protein biogenesis

• Human disease relevance investigation:

  • The human homolog ORAOV1 was initially identified as an oral cancer-overexpressed protein

  • Develop methodologies to study potential connections between Fe-S protein assembly and cancer biology

  • Use YAE1/YAE1D1 antibodies to analyze expression and localization in normal versus disease tissues

• Evolutionary divergence analysis:

  • Compare functions of YAE1 homologs across different species

  • Investigate species-specific interaction partners

  • This approach may reveal acquired or lost functions during evolution

These methodological approaches can help expand our understanding of YAE1 beyond its established role in the CIA machinery, potentially revealing novel functions in cellular homeostasis or disease contexts.